Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Vertical allometry: fact or fiction?

Mahmood I, Boxenbaum H.

Regul Toxicol Pharmacol. 2014 Apr;68(3):468-74. doi: 10.1016/j.yrtph.2014.02.005. Epub 2014 Feb 15.

PMID:
24534003
2.

The bioavailability of intranasal and smoked methamphetamine.

Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT.

Clin Pharmacol Ther. 2003 Nov;74(5):475-86.

PMID:
14586388
3.
4.

Commentary: does caloric restriction induce hormesis?

Boxenbaum H.

Hum Exp Toxicol. 2000 Jun;19(6):330-1. Review. No abstract available.

PMID:
10962499
7.

Pharmacokinetics tricks and traps: drug dosage adjustment in renal failure.

Boxenbaum H, Tannenbaum S, Mayersohn M, Oleson F.

J Pharm Pharm Sci. 1999 Jan-Apr;2(1):2-4. No abstract available.

8.

Pharmacokinetics tricks and traps: flip-flop models.

Boxenbaum H.

J Pharm Pharm Sci. 1998 Sep-Dec;1(3):90-1. No abstract available.

9.

Absorption potential and its variants.

Boxenbaum H.

Pharm Res. 1999 Dec;16(12):1893. No abstract available.

PMID:
10644080
10.

Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis.

Kakkar T, Boxenbaum H, Mayersohn M.

Drug Metab Dispos. 1999 Jun;27(6):756-62.

11.

Allometric analysis of organ extraction ratios.

Tannenbaum S, Boxenbaum H, Mayersohn M.

J Pharm Sci. 1997 Nov;86(11):1319-20. No abstract available.

PMID:
9383748
12.

First-time-in-human dose selection: allometric thoughts and perspectives.

Boxenbaum H, DiLea C.

J Clin Pharmacol. 1995 Oct;35(10):957-66. Review.

PMID:
8568013
13.

Effective half-life in clinical pharmacology.

Boxenbaum H, Battle M.

J Clin Pharmacol. 1995 Aug;35(8):763-6. No abstract available.

PMID:
8522631
14.

Human dolasetron pharmacokinetics: II. Absorption and disposition following single-dose oral administration to normal male subjects.

Boxenbaum H, Gillespie T, Heck K, Hahne W.

Biopharm Drug Dispos. 1993 Mar;14(2):131-41.

PMID:
8453023
15.

Human dolasetron pharmacokinetics: I. Disposition following single-dose intravenous administration to normal male subjects.

Boxenbaum H, Gillespie T, Heck K, Hahne W.

Biopharm Drug Dispos. 1992 Dec;13(9):693-701.

PMID:
1467456
16.

Pharmacokinetics: philosophy of modeling.

Boxenbaum H.

Drug Metab Rev. 1992;24(1):89-120. Review.

PMID:
1555495
17.

Gompertz mortality analysis: aging, longevity hormesis and toxicity.

Boxenbaum H.

Arch Gerontol Geriatr. 1991 Sep-Oct;13(2):125-37.

PMID:
15374423
18.

Scientific creativity: a review.

Boxenbaum H.

Drug Metab Rev. 1991;23(5-6):473-92. Review.

PMID:
1802653
19.
20.
21.

A Gompertz age-specific mortality rate model of aging, hormesis, and toxicity: dose-response studies.

Neafsey PJ, Boxenbaum H, Ciraulo DA, Fournier DJ.

Drug Metab Rev. 1989;20(1):111-50. No abstract available.

PMID:
2714196
22.

A Gompertz age-specific mortality rate model of aging: modification by dietary restriction in rats.

Neafsey PJ, Boxenbaum H, Ciraulo DA, Fournier DJ.

Drug Metab Rev. 1989;21(2):351-65.

PMID:
2636134
23.
24.

Human serum and plasma protein binding of enoximone and its sulfoxide metabolite.

Hook RH, Boxenbaum H, Thompson GA, Okerholm RA.

J Pharm Sci. 1988 Dec;77(12):1012-7.

PMID:
3244103
25.

Desmethyldiazepam pharmacokinetics: studies following intravenous and oral desmethyldiazepam, oral clorazepate, and intravenous diazepam.

Greenblatt DJ, Divoll MK, Soong MH, Boxenbaum HG, Harmatz JS, Shader RI.

J Clin Pharmacol. 1988 Sep;28(9):853-9.

PMID:
2906643
26.

Physiological pharmacokinetic models: some aspects of theory, practice and potential.

D'Souza RW, Boxenbaum H.

Toxicol Ind Health. 1988 Jun;4(2):151-71. Review.

PMID:
3051518
27.

ABSPLOTS: a LOTUS 123 spreadsheet for calculating and plotting drug absorption rates.

Shumaker RC, Boxenbaum H, Thompson GA.

Pharm Res. 1988 Apr;5(4):247-8. No abstract available.

PMID:
3247304
28.
29.

Hormesis, Gompertz functions, and risk assessment.

Boxenbaum H, Neafsey PJ, Fournier DJ.

Drug Metab Rev. 1988;19(2):195-229. Review.

PMID:
3069422
30.

A Gompertz age-specific mortality rate model of aging, hormesis, and toxicity: fixed-dose studies.

Neafsey PJ, Boxenbaum H, Ciraulo DA, Fournier DJ.

Drug Metab Rev. 1988;19(3-4):369-401. Review. Erratum in: Drug Metab Rev 1989;21(2):371-2.

PMID:
3068035
31.

Publication rates of pharmaceutical scientists: application of the waring distribution.

Boxenbaum H, Pivinski F, Ruberg SJ.

Drug Metab Rev. 1987;18(4):553-71.

PMID:
3371189
32.

Time concepts in physics, biology, and pharmacokinetics.

Boxenbaum H.

J Pharm Sci. 1986 Nov;75(11):1053-62.

PMID:
3820099
33.

Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin.

Greenblatt DJ, Abernethy DR, Boxenbaum HG, Matlis R, Ochs HR, Harmatz JS, Shader RI.

Arthritis Rheum. 1986 Aug;29(8):971-80.

PMID:
3741521
34.

Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.

Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB.

J Clin Pharmacol. 1986 Apr;26(4):292-8.

PMID:
2871050
35.

Pharmacokinetic interaction of disulfiram and antidepressants.

Ciraulo DA, Barnhill J, Boxenbaum H.

Am J Psychiatry. 1985 Nov;142(11):1373-4.

PMID:
4061700
36.

Mortality kinetics in toxicology studies.

Boxenbaum H, McCullough CB, Di Carlo FJ.

Drug Metab Rev. 1985-1986;16(3):321-62. Review. No abstract available.

PMID:
3914939
37.

Scaling of camptothecin plasma protein binding in 24 species.

Boxenbaum H, Fertig JB.

Biopharm Drug Dispos. 1984 Oct-Dec;5(4):405-8. No abstract available.

PMID:
6525446
38.

Alcoholism and mortality kinetics.

Boxenbaum H, Ciraulo D.

J Pharm Sci. 1984 Sep;73(9):1191-5.

PMID:
6491935
39.

Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species.

Boxenbaum H, Fertig JB.

Eur J Drug Metab Pharmacokinet. 1984 Apr-Jun;9(2):177-83.

PMID:
6745307
40.

Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms.

Boxenbaum H.

Pharm Res. 1984 Mar;1(2):82-8. doi: 10.1023/A:1016355431740.

PMID:
24277217
41.

Frequently cited references in contemporary pharmacokinetics.

Boxenbaum H, Pivinski F.

Drug Metab Rev. 1984-1985;15(7):1385-402. No abstract available.

PMID:
6398778
42.

Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm.

Boxenbaum H.

Drug Metab Rev. 1984;15(5-6):1071-121. Review. No abstract available.

PMID:
6396053
43.

Interspecies pharmacokinetic scaling and the Dedrick plots.

Boxenbaum H, Ronfeld R.

Am J Physiol. 1983 Dec;245(6):R768-75.

PMID:
6660320
44.
45.

Comparative pharmacokinetics of benzodiazepines in dog and man.

Boxenbaum H.

J Pharmacokinet Biopharm. 1982 Aug;10(4):411-26.

PMID:
6130139
46.

Literature growth in pharmacokinetics.

Boxenbaum H.

J Pharmacokinet Biopharm. 1982 Jun;10(3):335-48.

PMID:
7175703
47.

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Boxenbaum H.

J Pharmacokinet Biopharm. 1982 Apr;10(2):201-27. No abstract available.

PMID:
7120049
48.

Publication trends in the drug dependence literature.

Boxenbaum H, Jaffe JH.

Am J Drug Alcohol Abuse. 1982;9(1):55-68.

PMID:
6763473
49.

Influence of phenytoin and phenobarbital on the disposition of a single oral dose of clonazepam.

Khoo KC, Mendels J, Rothbart M, Garland WA, Colburn WA, Min BH, Lucek R, Carbone JJ, Boxenbaum HG, Kaplan SA.

Clin Pharmacol Ther. 1980 Sep;28(3):368-75.

PMID:
7408397

Supplemental Content

Loading ...
Support Center